1Gines A, Ecorsell A, Gines P, et al. Incidence, predicitive factors and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology,1993, 105:229-230.
2Schrier RW, Arroyo V, Bermardi M, et al. Peripheral arterial vasodilatation hypothesis: a proposal for the initiation of renal sodium and water retention on cirrhosis. Hepatology,1988,8:1151-1157.
3Arroyo V, Gines P, Gerbes AL, et al.Definitions and diagnostic certeria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology, 1996,23 : 164-176.
4Gentilini P, La VG, Laffi G, et al.Functional renal alterations in chronic liver diseases. Digestion, 1980, 20: 73-78.
5Bellomo R, Chapman M, Finfer S, etal. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomized trial. Lancet, 2000,356:2139-2143.
6Gulberg V, Bilzer M, Gerbes AL.Long-term therapy and retreatment of hepatorenal syndrome type I with ornipressin and dopamine . Hepatology,1999, 30:870-875.
7Hadengue A, Gadano A, Moreau R, et al. Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome. J Hepatol, 1998, 29:565-570.
8Uriz J, Gines P, Cardenas A, et al.Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome. J Hepatol, 2000, 33:43-48.
9Mulkay JP, Louis H, Donckier V.Long-term terlipressin administration improves renal function failure in cirrhotic patients with type I hepatorenal syndrome: a pilot study. Acta Gastroenterol Belg, 2001, 64:15-19.
10Angeli P, Volpin R, Gerunda G, et al.Reversal of type I hepatorenal syndrome with the administration of midodrine and octreotide. Hepatology, 1999, 29:1690-1697.
4Arroyo V, Gines P, Gerbes AL, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology, 1996,23 : 164-176.
5Carlo Catalano, Fabio Fabbian, Domenico DL, et al. Reinfusion and concentration of ascitic fluid during hemodialysis in a cirrhotic uremic patient. American Journal of Kidney Diseases, 1998,32: 164-167.
6DaVenport A. Is there a role for continuous renal replacement therapies in patients with liver and renal failure. Kidney Int, 1999,56: 62-66.
